We are committed to sustainable growth in both talent and products,
and contribute to the health and well-being of humanity through continuous innovation and equitable healthcare access.
Our Commitment
Our Strategy
-
Stable Continuously conduct quality system evalsuations to enhance compliance depth and strengthen the growth of quality capabilities and culture.
-
Mature Continuously improve the full lifecycle quality management system, optimize quality management platforms, and advance international quality management practices.
-
Efficient Continuously enhance digital information systems and implement quality talent development programs.
Our Initiatives
- Production Quality Management System
- Quality Culture
- Quality Testing
- Full Lifecycle Pharmacovigilance System
Our Achievements
-
10
10 production lines have successfully passed GMP compliance inspections conducted by the U.S. FDA, the European Union, and the World Health Organization (WHO).
-
15
15 APIs have passed FDA and WHO GMP compliance inspections.
-
>99%
The right first time for drug products exceeds 99%
-
100%
the pass rate for market sampling inspections is 100%
-
0
Zero product recalls due to quality-related issues
-
100%
Pharmaceutical subsidiaries comply 100% with GMP standards
-
100%
Quality training has been delivered to 100% of our employees
-
93hours per year per person
The average annual quality training for operation personnel is 93 hours per year per person
*As of December 31, 2024